Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
Patchy uptake of NPs dilutes progress on health outcomes
Wednesday 4 November 2020, 12:00 AM

Marie-Lyne Bournival
NPNZ
Nurse practitioners still find many barriers in the way of reaching the top of their scope, writes Marie-Lyne Bournival
One of the emerging issues underscored by the COVID-19 pandemic is that, in many countries, nurse practitioners are underutilised.
A recent article
References
Rosa WE, Fitzgerald M, Davis S, et al. Leveraging nurse practitioner capacities to achieve global health for all: COVID-19 and beyond. International Nursing Review 2020;00:1–6. (Online 2 October.)